Table 4. Antibiotic therapy for pyomyositis.
Disease classification | Antibiotic | Adult dose |
---|---|---|
Empirical therapy | Ampicillin/sulbactam or | 3 g q6 h IV |
cefepime or | 2 g q8 h IV | |
piperacillin/tazobactam or | 3.375–4.5 g q6–8 h IV | |
ertapenem | 1 g q24 h IV | |
Streptococcus | Penicillin | 2–4 million units q4–6 h IV |
Plus | ||
clindamycin | 600–900 mg q8 h IV | |
Methicillin-susceptible S. aureus | Nafcillin or | 1–2 g q4 h IV |
cefazolin | 1–2 g q8 h IV | |
Methicillin-resistance S. aureus | Vancomycin or | 15 mg/kg q12 h IV |
teicoplanin or | 6–12 mg/kg q24 h IV | |
linezolid | 600 mg q12 h IV |
IV, intravenous; PO, per os.